Trials / Completed
CompletedNCT05532592
Investigation on the Hesitancy of COVID-19 Vaccination Among Liver Transplant Recipients in China
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 449 (actual)
- Sponsor
- RenJi Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
On WeChat platform, through a point-to-point connection, and carry on the questionnaire survey to collect information of liver transplant recipients followed-up by the department of Liver Surgery, Renji Hospital Shanghai Jiao Tong University. Patients meeting inclusion and exclusion criteria will be selected. Conduct statistical analysis to describe the incidence of adverse reactions related to COVID-19 vaccine after liver transplantation, and to compare and evaluate the factors leading to COVID-19 vaccine hesitancy.
Detailed description
On WeChat platform, through a point-to-point connection, and carry on the questionnaire survey to collect information of liver transplant recipients followed-up by the department of Liver Surgery, Renji Hospital Shanghai Jiao Tong University. Questionnaire items including demographic characteristics, understanding of COVID-19, attitude toward COVID-19 vaccine. Patients meeting inclusion and exclusion criteria will be selected. Conduct statistical analysis to describe the incidence of adverse reactions related to COVID-19 vaccine after liver transplantation, and to compare and evaluate the factors leading to COVID-19 vaccine hesitancy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Perceptions and attitudes towards COVID-19 and COVID-19 vaccine | Attitude towards COVID-19; Knowledge about COVID-19 vaccine |
Timeline
- Start date
- 2022-04-27
- Primary completion
- 2022-05-10
- Completion
- 2022-05-30
- First posted
- 2022-09-08
- Last updated
- 2022-09-08
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05532592. Inclusion in this directory is not an endorsement.